| scholarly article | Q13442814 |
| P2093 | author name string | B J Brabin | |
| P2860 | cites work | CONTROLLED TRIAL OF PYRIMETHAMINE IN PREGNANT WOMEN IN AN AFRICAN VILLAGE | Q24682882 |
| THE DIAGNOSTIC VALUE OF THE PLACENTAL BLOOD FILM IN AESTIVO-AUTUMNAL MALARIA. | Q36241806 | ||
| Estimation of incidence and recovery rates of Plasmodium falciparum parasitaemia from longitudinal data | Q36630502 | ||
| Malaria infection of the placenta and its influence on the incidence of prematurity in eastern Nigeria | Q36880397 | ||
| The influence of malarial infection of the placenta on the incidence of prematurity | Q36881350 | ||
| Low birth-weight and malarial infection of the placenta | Q36910597 | ||
| Evaluation of fenitrothion for the control of malaria | Q38614132 | ||
| The role of malaria, folic acid deficiency and haemoglobin AS in pregnancy at Mulago hospital | Q38895515 | ||
| Topical aspects of the epidemiology of malaria | Q39207358 | ||
| Cause of anaemia in malaria | Q39544846 | ||
| Hypothesis: the importance of folacin in influencing susceptibility to malarial infection in infants | Q41620282 | ||
| Plasmodium malariae in the blood of pregnant and non-pregnant women in Abeokuta (West-Nigeria) | Q43459236 | ||
| On the control of malaria in Freetown, Sierra Leone; control methods and the effects upon the transmission of Plasmodium falciparum resulting from the reduced abundance of Anopheles gambiae | Q44162016 | ||
| Malaria, anaemia and pregnancy | Q45014349 | ||
| Frequency and causes of congenital malaria in West Africa | Q46595633 | ||
| Malaria in African infants and children in Southern Nigeria. | Q46642541 | ||
| Malarial immunity in Africans; effects in infancy and early childhood. | Q47853937 | ||
| Anaemia in parturient women, with special reference to malaria infection of the placenta | Q47967881 | ||
| The human materno-foetal relationship in malaria: I. Identification of pigment and parasites in the placenta | Q47973662 | ||
| Haemolytic anaemia in pregnancy in Nigeria: recognition by simple laboratory procedures | Q50726824 | ||
| Malaria and prematurity in the western region of Nigeria. | Q50731460 | ||
| Malaria Transmission and Fetal Growth | Q52478308 | ||
| Influence of maternal malaria on newborn infants | Q78466745 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | malaria | Q12156 |
| pregnancy-associated malaria | Q7239883 | ||
| P1104 | number of pages | 12 | |
| P304 | page(s) | 1005-1016 | |
| P577 | publication date | 1983-01-01 | |
| P1433 | published in | Bulletin of the World Health Organization | Q2928049 |
| P1476 | title | An analysis of malaria in pregnancy in Africa | |
| P478 | volume | 61 |
| Q49431533 | A brief review on features of falciparum malaria during pregnancy |
| Q36926693 | A community effectiveness trial of strategies promoting intermittent preventive treatment with sulphadoxine-pyrimethamine in pregnant women in rural Burkina Faso |
| Q36737343 | A model of parity-dependent immunity to placental malaria. |
| Q28469347 | A randomized controlled pilot trial of azithromycin or artesunate added to sulfadoxine-pyrimethamine as treatment for malaria in pregnant women |
| Q28469061 | A randomized controlled trial of folate supplementation when treating malaria in pregnancy with sulfadoxine-pyrimethamine |
| Q36794206 | A review of randomized controlled trials of routine antimalarial drug prophylaxis during pregnancy in endemic malarious areas |
| Q34360455 | A single member of the Plasmodium falciparum var multigene family determines cytoadhesion to the placental receptor chondroitin sulphate A. |
| Q33849072 | A well-conserved Plasmodium falciparum var gene shows an unusual stage-specific transcript pattern. |
| Q36015802 | ABO blood group phenotypes influence parity specific immunity to Plasmodium falciparum malaria in Malawian women |
| Q35016351 | ABO phenotypes and malaria related outcomes in mothers and babies in The Gambia: a role for histo-blood groups in placental malaria? |
| Q37024627 | Access and barriers to measures targeted to prevent malaria in pregnancy in rural Kenya |
| Q59794067 | Accuracy of One Step malaria rapid diagnostic test (RDT) in detecting Plasmodium falciparum placental malaria infection in women living in Yaoundé, Cameroon |
| Q37036133 | Adhesion of Plasmodium falciparum-infected erythrocytes to hyaluronic acid in placental malaria |
| Q37084492 | Adverse birth outcomes in United Republic of Tanzania--impact and prevention of maternal risk factors |
| Q39116049 | Adverse birth outcomes in a malarious area |
| Q33396980 | An upstream open reading frame controls translation of var2csa, a gene implicated in placental malaria |
| Q35938019 | Anaemia In Pregnancy In Malawi- A Review |
| Q24792921 | Analysis of IgG with specificity for variant surface antigens expressed by placental Plasmodium falciparum isolates |
| Q35360064 | Anemia associated with asymptomatic malaria among pregnant women in the rural surroundings of Arba Minch Town, South Ethiopia |
| Q35296614 | Anthropometry of fetal growth in rural Malawi in relation to maternal malaria and HIV status |
| Q34322250 | Anti-bacterial activity of intermittent preventive treatment of malaria in pregnancy: comparative in vitro study of sulphadoxine-pyrimethamine, mefloquine, and azithromycin |
| Q36718654 | Anti-malarial IgG subclasses pattern and FcγRIIa (CD32) polymorphism among pregnancy-associated malaria in semi-immune Saudi women. |
| Q36576445 | Antibodies that inhibit binding of Plasmodium falciparum-infected erythrocytes to chondroitin sulfate A and to the C terminus of merozoite surface protein 1 correlate with reduced placental malaria in Cameroonian women |
| Q37036128 | Antibodies to variant surface antigens of Plasmodium falciparum-infected erythrocytes and adhesion inhibitory antibodies are associated with placental malaria and have overlapping and distinct targets |
| Q36794814 | Antimalarials during pregnancy: a cost-effectiveness analysis |
| Q36644765 | Artemether-Lumefantrine Pharmacokinetics and Clinical Response Are Minimally Altered in Pregnant Ugandan Women Treated for Uncomplicated Falciparum Malaria. |
| Q37406034 | Association between malaria immunity and pregnancy outcomes among Malawian pregnant women receiving nutrient supplementation |
| Q56341834 | Association of Antibodies to VAR2CSA and Merozoite Antigens with Pregnancy Outcomes in Women Living in Yaoundé, Cameroon |
| Q34592149 | Associations between peripheral Plasmodium falciparum malaria parasitemia, human immunodeficiency virus, and concurrent helminthic infection among pregnant women in Malawi |
| Q37686396 | Asymptomatic Plasmodium falciparum infection is associated with anaemia in pregnancy and can be more cost-effectively detected by rapid diagnostic test than by microscopy in Kinshasa, Democratic Republic of the Congo |
| Q33654974 | Asymptomatic Plasmodium falciparum malaria in pregnant women in the Chittagong Hill Districts of Bangladesh |
| Q35205935 | Azithromycin plus chloroquine: combination therapy for protection against malaria and sexually transmitted infections in pregnancy |
| Q37076814 | Azithromycin-chloroquine and the intermittent preventive treatment of malaria in pregnancy |
| Q33420846 | C5a enhances dysregulated inflammatory and angiogenic responses to malaria in vitro: potential implications for placental malaria. |
| Q35287217 | Causes of preterm delivery and intrauterine growth retardation in a malaria endemic region of Papua New Guinea |
| Q37625184 | Characterization of human placental glycosaminoglycans and regional binding to VAR2CSA in malaria infected erythrocytes |
| Q34934975 | Chondroitin sulfate proteoglycan expression and binding of Plasmodium falciparum-infected erythrocytes in the human placenta during pregnancy. |
| Q33287101 | Chronic steroid administration does not suppress Plasmodium development and maturation |
| Q37263318 | Clinical development of placental malaria vaccines and immunoassays harmonization: a workshop report |
| Q37424929 | Clinical signs and symptoms cannot reliably predict Plasmodium falciparum malaria infection in pregnant women living in an area of high seasonal transmission. |
| Q35170521 | Comparison of chloroquine, pyrimethamine and sulfadoxine, and chlorproguanil and dapsone as treatment for falciparum malaria in pregnant and non-pregnant women, Kakamega District, Kenya |
| Q36840743 | Congenital Plasmodium falciparum malaria in sub-Saharan Africa: a rarity or frequent occurrence? |
| Q33769127 | Cross-reactive surface epitopes on chondroitin sulfate A-adherent Plasmodium falciparum-infected erythrocytes are associated with transcription of var2csa |
| Q36327851 | Decline of placental malaria in southern Ghana after the implementation of intermittent preventive treatment in pregnancy |
| Q35250816 | Detection and clinical manifestation of placental malaria in southern Ghana |
| Q33962574 | Detection of the Plasmodium falciparum antigen histidine-rich protein 2 in blood of pregnant women: implications for diagnosing placental malaria |
| Q35623113 | Determinants of Anaemia in Pregnancy in Sekyere West District, Ghana |
| Q34152018 | Determinants of insecticide-treated net ownership and utilization among pregnant women in nigeria |
| Q36799463 | Determinants of low birth weight: methodological assessment and meta-analysis |
| Q36555631 | Diagnosing malaria in pregnancy: an update |
| Q37014213 | Diagnosis of Plasmodium falciparum malaria in pregnancy in sub-Saharan Africa: the challenges and public health implications |
| Q27349502 | Differential induction of functional IgG using the Plasmodium falciparum placental malaria vaccine candidate VAR2CSA |
| Q33532592 | Differential recognition of P. falciparum VAR2CSA domains by naturally acquired antibodies in pregnant women from a malaria endemic area |
| Q33299476 | Disruption of var2csa gene impairs placental malaria associated adhesion phenotype |
| Q56362112 | Down-selection of the VAR2CSA DBL1-2 expressed in as a lead antigen for placental malaria vaccine development |
| Q33721310 | Dynamics in the cytoadherence phenotypes of Plasmodium falciparum infected erythrocytes isolated during pregnancy |
| Q33733730 | Effect of IPTp on Plasmodium falciparum antibody levels among pregnant women and their babies in a sub-urban coastal area in Ghana |
| Q36466975 | Effectiveness of intermittent preventive treatment with sulfadoxine-pyrimethamine during pregnancy on maternal and birth outcomes in Machinga district, Malawi |
| Q53685488 | Effects of Weekly Iron and Folic Acid Supplements on Malaria Risk in Nulliparous Women in Burkina Faso: A Periconceptional Double-blind Randomized Controlled Non-inferiority Trial. |
| Q33883435 | Effects of pregnancy and intensity of Plasmodium falciparum transmission on immunoglobulin G subclass responses to variant surface antigens |
| Q34383001 | Efficacy of malaria prevention during pregnancy in an area of low and unstable transmission: an individually-randomised placebo-controlled trial using intermittent preventive treatment and insecticide-treated nets in the Kabale Highlands, southweste |
| Q36539570 | Elevated gamma interferon-producing NK cells, CD45RO memory-like T cells, and CD4 T cells are associated with protection against malaria infection in pregnancy |
| Q36348741 | Epidemiology and Risk Analysis of Malaria among Pregnant Women. |
| Q33263953 | Epitope mapping and topographic analysis of VAR2CSA DBL3X involved in P. falciparum placental sequestration |
| Q34576841 | Evaluation of prevalence's of pfdhfr and pfdhps mutations in Angola |
| Q34364093 | Evidence for the involvement of VAR2CSA in pregnancy-associated malaria |
| Q47862113 | Evolutionary analysis of genes of two pathways involved in placental malaria infection |
| Q24535657 | Evolutionary and historical aspects of the burden of malaria |
| Q64065682 | Excess risk of preterm birth with periconceptional iron supplementation in a malaria endemic area: analysis of secondary data on birth outcomes in a double blind randomized controlled safety trial in Burkina Faso |
| Q34715375 | Expression of variant surface antigens by Plasmodium falciparum parasites in the peripheral blood of clinically immune pregnant women indicates ongoing placental infection |
| Q37359751 | Factors associated with risk of malaria infection among pregnant women in Lagos, Nigeria. |
| Q36973292 | Factors associated with the failure of Intermittent Preventive Treatment for malaria among pregnant women in Yaounde |
| Q33626397 | First-trimester artemisinin derivatives and quinine treatments and the risk of adverse pregnancy outcomes in Africa and Asia: A meta-analysis of observational studies |
| Q37144998 | Genetic polymorphisms of mannose-binding lectin do not influence placental malaria but are associated with preterm deliveries |
| Q34009705 | Gravidity-dependent production of antibodies that inhibit binding of Plasmodium falciparum-infected erythrocytes to placental chondroitin sulfate proteoglycan during pregnancy |
| Q24800632 | HIV, malaria and beyond: reducing the disease burden of female adolescents |
| Q28552340 | HRP2 and pLDH-Based Rapid Diagnostic Tests, Expert Microscopy, and PCR for Detection of Malaria Infection during Pregnancy and at Delivery in Areas of Varied Transmission: A Prospective Cohort Study in Burkina Faso and Uganda |
| Q93604485 | Hamatological parameters and malaria parasite infection among pregnant women in Northwest Nigeria |
| Q36088581 | Heterologous Infection of Pregnant Mice Induces Low Birth Weight and Modifies Offspring Susceptibility to Malaria |
| Q34326742 | High avidity antibodies to full-length VAR2CSA correlate with absence of placental malaria |
| Q35794314 | High burden of malaria infection in pregnant women in a rural district of Zambia: a cross-sectional study |
| Q35867607 | High levels of antibodies to multiple domains and strains of VAR2CSA correlate with the absence of placental malaria in Cameroonian women living in an area of high Plasmodium falciparum transmission |
| Q34591148 | High plasma levels of HLA-G are associated with low birth weight and with an increased risk of malaria in infancy |
| Q36940415 | High rates of parasite recrudescence following intermittent preventive treatment with sulphadoxine-pyrimethamine during pregnancy in Benin |
| Q33627466 | High-throughput pooling and real-time PCR-based strategy for malaria detection |
| Q33806360 | Histopathologies, immunolocalization, and a glycan binding screen provide insights into Plasmodium falciparum interactions with the human placenta |
| Q55112496 | Human Genetic Markers and Structural Prediction of Plasmodium falciparum Multidrug Resistance Gene (pfmdr1) for Ligand Binding in Pregnant Women Attending General Hospital Minna. |
| Q34062601 | IFN-gamma and TNF associated with severe falciparum malaria infection in Saudi pregnant women. |
| Q33340867 | Identification of glycosaminoglycan binding regions in the Plasmodium falciparum encoded placental sequestration ligand, VAR2CSA |
| Q53819699 | IgM and IgG against Plasmodium falciparum lysate as surrogates of malaria exposure and protection during pregnancy. |
| Q35073950 | Immunogenicity of Duffy binding-like domains that bind chondroitin sulfate A and protection against pregnancy-associated malaria |
| Q36175661 | Immunoglobulins against the surface of Plasmodium falciparum-infected erythrocytes increase one month after delivery |
| Q30245481 | Impact of In Utero Exposure to Malaria on Fetal T Cell Immunity |
| Q36539086 | Impact of human immunodeficiency virus infection in pregnant women on variant-specific immunity to malaria |
| Q36274941 | Impact of placental Plasmodium falciparum malaria on pregnancy and perinatal outcome in sub-Saharan Africa: I: introduction to placental malaria |
| Q33380234 | Impact of placental Plasmodium falciparum malaria on pregnancy and perinatal outcome in sub-Saharan Africa: part III: placental malaria, maternal health, and public health. |
| Q37433820 | Implementing Intermittent Preventive Treatment for Malaria in Pregnancy: Review of Prospects, Achievements, Challenges and Agenda for Research |
| Q48021387 | Increased Susceptibility to Plasmodium falciparum in Infants is associated with Low, not High, Placental Malaria Parasitemia |
| Q38860337 | Increased prevalence of intestinal helminth infection during pregnancy in a Sub-Saharan African community |
| Q26830867 | Inflammation and Nutritional Science for Programs/Policies and Interpretation of Research Evidence (INSPIRE). |
| Q47831862 | Inflammatory reactions in placental blood of Plasmodium falciparum-infected women and high concentrations of soluble E-selectin and a circulating P. falciparum protein in the cord sera |
| Q36644516 | Influence of Intermittent Preventive Treatment on Antibodies to VAR2CSA in Pregnant Cameroonian Women |
| Q37201119 | Influence of human chorionic gonadotropin (hCG) on in vitro growth of Plasmodium falciparum |
| Q34875809 | Influence of pregnancy on Trypanosoma cruzi parasitemia in chronically infected women in a rural Bolivian community |
| Q33820246 | Influence of the number and timing of malaria episodes during pregnancy on prematurity and small-for-gestational-age in an area of low transmission |
| Q35131357 | Influence of the timing of malaria infection during pregnancy on birth weight and on maternal anemia in Benin |
| Q34005689 | Inhibition of adhesion of Plasmodium falciparum-infected erythrocytes by structurally defined hyaluronic acid dodecasaccharides |
| Q33883564 | Inhibition of chondroitin-4-sulfate-specific adhesion of Plasmodium falciparum-infected erythrocytes by sulfated polysaccharides |
| Q24246203 | Insecticide-treated nets for preventing malaria in pregnancy |
| Q28763143 | Insecticide-treated nets for the prevention of malaria in pregnancy: a systematic review of randomised controlled trials |
| Q56360397 | Integrated point-of-care testing (POCT) of HIV, syphilis, malaria and anaemia in antenatal clinics in western Kenya: A longitudinal implementation study |
| Q34537157 | Interactions between natural killer cells, cortisol and prolactin in malaria during pregnancy |
| Q37521618 | Intermittent preventive sulfadoxine-pyrimethamine treatment of primigravidae reduces levels of plasma immunoglobulin G, which protects against pregnancy-associated Plasmodium falciparum malaria |
| Q28543146 | Intermittent preventive treatment of malaria in pregnancy with mefloquine in HIV-negative women: a multicentre randomized controlled trial |
| Q35928610 | Intermittent preventive treatment with sulphadoxine-pyrimethamine is effective in preventing maternal and placental malaria in Ibadan, south-western Nigeria |
| Q36997142 | Iron Supplementation in Iron-Replete and Nonanemic Pregnant Women in Tanzania: A Randomized Clinical Trial |
| Q42383566 | Iron, Inflammation, and Malaria in the Pregnant Woman and Her Child: Saving Lives, Saving Brains |
| Q35677598 | Is chloroquine chemoprophylaxis still effective to prevent low birth weight? Results of a study in Benin |
| Q38959045 | Is it feasible to give insecticide-treated bednets free to pregnant women? |
| Q40129832 | Isolation and Characterization of Vaccine Candidate Genes Including CSP and MSP1 in Plasmodium yoelii |
| Q33630156 | Kinetics of B cell responses to plasmodium falciparum erythrocyte membrane protein 1 in ghanaian women naturally exposed to malaria parasites |
| Q35106301 | Lack of gender-specific antibody recognition of products from domains of a var gene implicated in pregnancy-associated Plasmodium falciparum malaria |
| Q35139945 | Levels of macrophage inflammatory protein 1 alpha (MIP-1 alpha) and MIP-1 beta in intervillous blood plasma samples from women with placental malaria and human immunodeficiency virus infection |
| Q34239984 | Longitudinal studies of Plasmodium falciparum malaria in pregnant women living in a rural Cameroonian village with high perennial transmission |
| Q36462673 | Malaria and gravidity interact to modify maternal haemoglobin concentrations during pregnancy. |
| Q34790559 | Malaria associated symptoms in pregnant women followed-up in Benin |
| Q35751895 | Malaria burden in pregnancy at mulago national referral hospital in kampala, Uganda |
| Q43201955 | Malaria control in pregnancy: still a long way to go. |
| Q36284603 | Malaria during Pregnancy |
| Q24815923 | Malaria during pregnancy and foetal haematological status in Blantyre, Malawi |
| Q37309935 | Malaria has no effect on birth weight in Rwanda |
| Q81266084 | Malaria in pregnancy |
| Q37315138 | Malaria in pregnancy in rural Gabon: a cross-sectional survey on the impact of seasonality in high-risk groups |
| Q41990397 | Malaria in pregnancy: the relevance of animal models for vaccine development. |
| Q34409815 | Malaria parasite detection increases during pregnancy in wild chimpanzees |
| Q35666958 | Malaria preventive therapy in pregnancy and its potential impact on immunity to malaria in an area of declining transmission |
| Q37703655 | Malarial Infection among Antenatal and Maternity Clinics Attendees at the Federal Medical Centre, Makurdi, Benue State, Nigeria |
| Q37835430 | Malarial Infection and Curable Sexually Transmitted and Reproductive Tract Infections Among Pregnant Women in a Rural District of Zambia |
| Q48022331 | Matched Placental and Circulating Plasmodium falciparum Parasites are Genetically Homologous at the var2csa ID1-DBL2X Locus by Deep Sequencing |
| Q62488463 | Mefloquine for preventing malaria in pregnant women |
| Q51737259 | Mefloquine for preventing malaria in pregnant women. |
| Q24599164 | Mefloquine safety and tolerability in pregnancy: a systematic literature review |
| Q34610759 | Molecular Detection of Plasmodium falciparum Infection in Matched Peripheral and Placental Blood Samples from Delivering Women in Libreville, Gabon |
| Q64076612 | Molecular Principles of Intrauterine Growth Restriction in Plasmodium Falciparum Infection |
| Q37018621 | Monitoring and evaluation of malaria in pregnancy - developing a rational basis for control |
| Q37647647 | Naturally Acquired Binding-Inhibitory Antibodies to Plasmodium vivax Duffy Binding Protein in Pregnant Women Are Associated with Higher Birth Weight in a Multicenter Study |
| Q35624423 | Newborn splenic volumes vary under different malaria endemic conditions |
| Q35025223 | Nonimmune immunoglobulin binding and multiple adhesion characterize Plasmodium falciparum-infected erythrocytes of placental origin |
| Q34740303 | Parity and placental infection affect antibody responses against Plasmodium falciparum during pregnancy |
| Q36796835 | Perceptions and practices for preventing malaria in pregnancy in a peri-urban setting in south-western Uganda |
| Q38282573 | Perioperative considerations of the patient with malaria |
| Q34484783 | Persistence of Plasmodium falciparum parasites in infected pregnant Mozambican women after delivery |
| Q34034413 | Pharmacokinetics of co-formulated mefloquine and artesunate in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum infection in Burkina Faso |
| Q36080121 | Pharmacokinetics of piperaquine in pregnant women in Sudan with uncomplicated Plasmodium falciparum malaria |
| Q41716199 | Placental malaria and its effect on pregnancy outcomes in Sudanese women from Blue Nile State |
| Q37402159 | Placental malaria and low birth weight in pregnant women living in a rural area of Burkina Faso following the use of three preventive treatment regimens |
| Q34034060 | Placental malaria induces variant-specific antibodies of the cytophilic subtypes immunoglobulin G1 (IgG1) and IgG3 that correlate with adhesion inhibitory activity |
| Q36006055 | Placental malaria prevalence of infestation amongst febrile pregnant women in central India: maternal and perinatal outcome |
| Q48022973 | Plasmodium falciparum genetic variation of var2csa in the Democratic Republic of the Congo |
| Q37036123 | Plasmodium falciparum isolates from infected pregnant women and children are associated with distinct adhesive and antigenic properties |
| Q36394496 | Plasmodium falciparum parasitaemia in the first half of pregnancy, uterine and umbilical artery blood flow, and foetal growth: a longitudinal Doppler ultrasound study |
| Q34063668 | Plasmodium falciparum parasites causing cerebral malaria share variant surface antigens, but are they specific? |
| Q34003113 | Plasmodium falciparum rosette formation is uncommon in isolates from pregnant women |
| Q35098438 | Plasmodium falciparum-infected erythrocytes adhere both in the intervillous space and on the villous surface of human placenta by binding to the low-sulfated chondroitin sulfate proteoglycan receptor |
| Q37354879 | Plasmodium falciparum: Assessment of parasite-infected red blood cell binding to placental chondroitin proteoglycan and bovine tracheal chondroitin sulfate A. |
| Q36255388 | Population-based prevalence of malaria among pregnant women in Enugu State, Nigeria: the Healthy Beginning Initiative |
| Q34988334 | Positive selection of Plasmodium falciparum parasites with multiple var2csa-type PfEMP1 genes during the course of infection in pregnant women |
| Q64086386 | Preclinical immunogenicity and safety of the cGMP-grade placental malaria vaccine PRIMVAC |
| Q26827604 | Pregnancy and infection |
| Q27005799 | Pregnancy and susceptibility to infectious diseases |
| Q44573290 | Pregnancy and use of oral contraceptives reduces the biotransformation of proguanil to cycloguanil |
| Q37258037 | Pregnancy-Associated Malaria in a Rural Community of Ghana |
| Q33963392 | Pregnancy-associated malaria and malaria in infants: an old problem with present consequences |
| Q34736220 | Prescription patterns and drug use among pregnant women with febrile Illnesses in Uganda: a survey in out-patient clinics |
| Q98215648 | Prevalence and associated factors of malaria among pregnant women in Sherkole district, Benishangul Gumuz regional state, West Ethiopia |
| Q34558626 | Prevalence and risk factors for Plasmodium falciparum malaria in pregnant women attending antenatal clinic in Bobo-Dioulasso (Burkina Faso). |
| Q24795315 | Prevalence and risk factors for Plasmodium falciparum malaria in pregnant women of eastern Sudan |
| Q36343129 | Prevalence of Plasmodium falciparum Malaria among Pregnant Students in Dodoma Region, Tanzania: No Cases Have Been Detected |
| Q24794494 | Prevalence of Plasmodium falciparum infection in pregnant women in Gabon |
| Q35960861 | Prevalence of Plasmodium falciparum resistance markers to sulfadoxine-pyrimethamine among pregnant women receiving intermittent preventive treatment for malaria in Uganda |
| Q21034051 | Prevalence of congenital malaria in high-risk Ghanaian newborns: a cross-sectional study. |
| Q37624137 | Prevalence of peripheral blood parasitaemia, anaemia and low birthweight among pregnant women in a suburban area in coastal Ghana |
| Q35738477 | Prospects and Pitfalls of Pregnancy-Associated Malaria Vaccination Based on the Natural Immune Response to Plasmodium falciparum VAR2CSA-Expressing Parasites |
| Q33769097 | Rapid acquisition of isolate-specific antibodies to chondroitin sulfate A-adherent plasmodium falciparum isolates in Ghanaian primigravidae |
| Q34317292 | Rational case management of malaria with a rapid diagnostic test, Paracheck Pf®, in antenatal health care in Bangui, Central African Republic |
| Q40206336 | Regioselectively modified sulfated cellulose as prospective drug for treatment of malaria tropica |
| Q42634261 | Risk factors and pregnancy outcomes associated with placental malaria in a prospective cohort of Papua New Guinean women |
| Q58698512 | Safety Profile of Drug Use During Pregnancy at Peripheral Health Centres in Burkina Faso: A Prospective Observational Cohort Study |
| Q33835894 | Safety and benefits of antenatal oral iron supplementation in low-income countries: a review |
| Q34132871 | Selective accumulation of mature asexual stages of Plasmodium falciparum-infected erythrocytes in the placenta |
| Q33634689 | Several domains from VAR2CSA can induce Plasmodium falciparum adhesion-blocking antibodies |
| Q47866627 | Severe anaemia in pregnancy: a problem of primigravidae in rural Zaire |
| Q36505266 | Sex differentials in susceptibility to lymphatic filariasis and implications for maternal child immunity |
| Q36078717 | Structural and functional insight into how the Plasmodium falciparum VAR2CSA protein mediates binding to chondroitin sulfate A in placental malaria. |
| Q37177187 | Structural insights into chondroitin sulphate A binding Duffy-binding-like domains from Plasmodium falciparum: implications for intervention strategies against placental malaria |
| Q35913444 | Submicroscopic and multiple plasmodium falciparum infections in pregnant Sudanese women |
| Q50047198 | Submicroscopic placental infection by non-falciparum Plasmodium spp |
| Q33589254 | Sulfadoxine-Pyrimethamine Exhibits Dose-Response Protection Against Adverse Birth Outcomes Related to Malaria and Sexually Transmitted and Reproductive Tract Infections |
| Q38622146 | Surveillance in easy to access population subgroups as a tool for evaluating malaria control progress: A systematic review |
| Q34461507 | The Malaria in Pregnancy Library: a bibliometric review. |
| Q36339851 | The adhesion of Plasmodium falciparum-infected erythrocytes to chondroitin sulfate A is mediated by P. falciparum erythrocyte membrane protein 1. |
| Q46811065 | The association of anti-phospholipid antibodies with parity in placental malaria |
| Q33578805 | The effect of malaria and intestinal helminth coinfection on birth outcomes in Kumasi, Ghana |
| Q36834270 | The effect of timing and frequency of Plasmodium falciparum infection during pregnancy on the risk of low birth weight and maternal anemia |
| Q39133249 | The impact of IgG antibodies to recombinant Plasmodium falciparum 732var CIDR-1alpha domain in mothers and their newborn babies |
| Q35110725 | The impact of endemic and epidemic malaria on the risk of stillbirth in two areas of Tanzania with different malaria transmission patterns |
| Q36875543 | The influence of malaria and gestation on the immune response to one and two doses of adsorbed tetanus toxoid in pregnancy |
| Q36224221 | The prevalence of malaria at first antenatal visit in Blantyre, Malawi declined following a universal bed net campaign |
| Q33849067 | The role of Plasmodium falciparum var genes in malaria in pregnancy. |
| Q37402165 | The use of schools for malaria surveillance and programme evaluation in Africa |
| Q34944810 | Therapeutic efficacy of sulphadoxine-pyrimethamine and chloroquine for the treatment of uncomplicated malaria in pregnancy in Burkina Faso. |
| Q33402698 | Thrombocytopenia in pregnant women with Plasmodium falciparum malaria in an area of unstable malaria transmission in eastern Sudan |
| Q36677067 | Timing of intermittent preventive treatment for malaria during pregnancy and the implications of current policy on early uptake in north-east Tanzania |
| Q35838605 | Transcription of var genes other than var2csa in Plasmodium falciparum parasites infecting Mozambican pregnant women |
| Q33751699 | Utilisation of insecticide treated nets among pregnant women in Gulu: a post conflict district in northern Uganda |
| Q36605922 | Utilization of intermittent preventive treatment of malaria by pregnant women in rivers state, Nigeria |
| Q40670564 | VAR2CSA Domain-Specific Analysis of Naturally Acquired Functional Antibodies to Plasmodium falciparum Placental Malaria |
| Q45973300 | Variant surface antigens in cerebral malaria: distinct from others and similar to each other? |
| Q36299176 | Zinc erythrocyte protoporphyrin as marker of malaria risk in pregnancy - a retrospective cross-sectional and longitudinal study |
Search more.